Know Cancer

or
forgot password

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation


Phase 2/Phase 3
20 Years
N/A
Not Enrolling
Both
Adrenal Gland Neoplasms

Thank you

Trial Information

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation


Adrenal radiofrequency (RF) ablation has been increasingly used for the treatment of
unresectable adrenal tumors. But one of the major complication is a increase in blood
pressure. Hormonal release during RF ablation is considered the cause of hypertension. But
there has been no evidence that adrenal hormones affects changes in blood pressure. In this
prospective study, we evaluate the changes in adrenal hormones during RF ablation and
clarify the cause of hypertensive crisis.


Inclusion Criteria:



- Unresectable adrenal tumor which will be treated by radiofrequency (RF)ablation

- Blood pressure is 140mmHg or less before RF ablation

- Age of 20-years or more

- Performance status of 0 or 1

- Agreement from the patient

Exclusion Criteria:

- Platelet count of 50,000/mm^3 or International normalized ratio (INR)>1.5

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Increase in Catecholamine

Outcome Time Frame:

One day

Safety Issue:

No

Principal Investigator

Koichiro Yamakado, MD

Investigator Role:

Study Chair

Investigator Affiliation:

Mie University School of Medicine

Authority:

Japan: Ministry of Health, Labor and Welfare

Study ID:

274

NCT ID:

NCT00997594

Start Date:

October 2009

Completion Date:

Related Keywords:

  • Adrenal Gland Neoplasms
  • adrenal gland
  • Adrenal Gland Neoplasms
  • Neoplasms

Name

Location